drugset / Trial / NCT07241104
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of the study is to assess the safety, tolerability and the pharmacokinetics (PK) of AZD4063 after single and multiple dose administration in participants with phospholamban (PLN) R14del dilated cardiomyopathy.
Timeline
- Start
- 2025-12-01
- Primary completion
- 2027-11-22
- Completion
- 2027-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD4063 | Unknown | — | Subcutaneous |